BNP Paribas Financial Markets
MIRM icon

BNP Paribas Financial Markets’s Mirum Pharmaceuticals MIRM Stock Holding History

BNP Paribas Financial Markets’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71M Sell
606,427
-304,992
-33% -$30.6M 0.02% 593
2026
Q1 		$84.2M Buy
911,419
+255,641
+39% +$24M 0.04% 458
2025
Q4 		$51.8M Buy
655,778
+54,705
+9% +$3.93M 0.02% 668
2025
Q3 		$44.1M Buy
601,073
+119,609
+25% +$7.6M 0.02% 686
2025
Q2 		$24.5M Sell
481,464
-17,719
-4% -$789K 0.01% 938
2025
Q1 		$22.5M Buy
499,183
+237,539
+91% +$11.2M 0.01% 981
2024
Q4 		$10.8M Buy
+261,644
New +$10.9M 0.01% 1313

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets's MIRM Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Mirum Pharmaceuticals (MIRM) stake by 33% in Q2 2026, selling an estimated $30.6M and leaving 606,427 shares worth $71M. The position accounts for 0.02% of the portfolio, ranked #593.

BNP Paribas Financial Markets first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. The position peaked at $84.2M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • BNP Paribas Financial Markets held 606,427 shares of Mirum Pharmaceuticals worth $71M as of Q2 2026.
  • BNP Paribas Financial Markets sold 304,992 Mirum Pharmaceuticals shares in Q2 2026, an estimated $30.6M.
  • Mirum Pharmaceuticals made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #593 holding.
  • BNP Paribas Financial Markets first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Mirum Pharmaceuticals position peaked at $84.2M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.